BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17713470)

  • 1. PharmGKB: the Pharmacogenetics Knowledge Base.
    Hewett M; Oliver DE; Rubin DL; Easton KL; Stuart JM; Altman RB; Klein TE
    Nucleic Acids Res; 2002 Jan; 30(1):163-5. PubMed ID: 11752281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PharmGKB: A worldwide resource for pharmacogenomic information.
    Barbarino JM; Whirl-Carrillo M; Altman RB; Klein TE
    Wiley Interdiscip Rev Syst Biol Med; 2018 Jul; 10(4):e1417. PubMed ID: 29474005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying aberrant pathways through integrated analysis of knowledge in pharmacogenomics.
    Hoehndorf R; Dumontier M; Gkoutos GV
    Bioinformatics; 2012 Aug; 28(16):2169-75. PubMed ID: 22711793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetic and pharmacogenomic treatment of rheumatoid arthritis: a review of Pharmacogenomics Knowledge Base scientific evidence.
    Dorado P; M Peñas-Lledó E
    Pharmacogenomics; 2024 Jan; 25(2):55-58. PubMed ID: 38230665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing Ancestry and Sex Bias in Pharmacogenomics.
    Corpas M; Siddiqui MK; Soremekun O; Mathur R; Gill D; Fatumo S
    Annu Rev Pharmacol Toxicol; 2024 Jan; 64():53-64. PubMed ID: 37450899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics and big genomic data: from lab to clinic and back again.
    Lavertu A; McInnes G; Daneshjou R; Whirl-Carrillo M; Klein TE; Altman RB
    Hum Mol Genet; 2018 May; 27(R1):R72-R78. PubMed ID: 29635477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Star allele search: a pharmacogenetic annotation database and user-friendly search tool of publicly available 1000 Genomes Project biospecimens.
    Gharani N; Calendo G; Kusic D; Madzo J; Scheinfeldt L
    BMC Genomics; 2024 Jan; 25(1):116. PubMed ID: 38279110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of pharmacogenomic variants associated with population differentiation.
    Yeon B; Ahn E; Kim KI; Kim IW; Oh JM; Park T
    PLoS One; 2015; 10(3):e0119994. PubMed ID: 25807276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing.
    Cavallari LH; Pratt VM
    Clin Lab Med; 2022 Dec; 42(4):533-546. PubMed ID: 36368780
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial: Pharmacogenetic landscape in human solid cancers.
    Lastraioli E; Colombo F; Frullanti E
    Front Oncol; 2023; 13():1343395. PubMed ID: 38260860
    [No Abstract]   [Full Text] [Related]  

  • 11. Engaging Students in Pharmacogenetics: Patient Case Studies Using the PharmGKB Website.
    Mosquera AM; Aleksunes LM
    CourseSource; 2023; 10():. PubMed ID: 37476533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Very Important Pharmacogenomics Variants in the Chinese Lahu Population.
    Cheng Y; Li Q; Yang X; Ding H; Chen W; Dai R; Zhang C
    Pharmgenomics Pers Med; 2021; 14():1275-1289. PubMed ID: 34629888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From gene networks to drugs: systems pharmacology approaches for AUD.
    Ferguson LB; Harris RA; Mayfield RD
    Psychopharmacology (Berl); 2018 Jun; 235(6):1635-1662. PubMed ID: 29497781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bringing clinical pharmacogenomics information to pharmacists: A qualitative study of information needs and resource requirements.
    Romagnoli KM; Boyce RD; Empey PE; Adams S; Hochheiser H
    Int J Med Inform; 2016 Feb; 86():54-61. PubMed ID: 26725696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systems biology approaches to adverse drug effects: the example of cardio-oncology.
    Brown SA; Sandhu N; Herrmann J
    Nat Rev Clin Oncol; 2015 Dec; 12(12):718-31. PubMed ID: 26462128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized chemotherapy for osteosarcoma and identification of gene mutations in osteosarcoma.
    Xiao X; Wang W; Zhang H; Gao P; Fan B; Huang C; Fu J; Chen G; Shi L; Zhu H; Li X; Li J; Fan H; Wu Z; Guo Z; Hu Y; Wu S; Yu X; Xu C; Wang Z
    Tumour Biol; 2015 Apr; 36(4):2427-35. PubMed ID: 25431261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinician adoption of genetic testing for drug metabolizing enzymes: is patient safety the low-hanging fruit of personalized medicine?
    Enchin H
    AMIA Annu Symp Proc; 2009 Nov; 2009():168-72. PubMed ID: 20351843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PharmGKB: understanding the effects of individual genetic variants.
    Sangkuhl K; Berlin DS; Altman RB; Klein TE
    Drug Metab Rev; 2008; 40(4):539-51. PubMed ID: 18949600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB).
    Owen RP; Klein TE; Altman RB
    Clin Pharmacol Ther; 2007 Oct; 82(4):472-5. PubMed ID: 17713470
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.